Travere Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $346k | 38k | 8.99 |
| 2023-09-30 | $344k | 38k | 8.94 |
| 2023-06-30 | $590k | 38k | 15.36 |
| 2023-03-31 | $731k | 33k | 22.49 |
| 2022-12-31 | $684k | 33k | 21.03 |
| 2022-09-30 | $801k | 33k | 24.64 |
| 2022-06-30 | $788k | 33k | 24.23 |
| 2022-03-31 | $871k | 34k | 25.77 |
| 2021-12-31 | $662k | 21k | 31.04 |
| 2021-09-30 | $517k | 21k | 24.25 |
| 2021-06-30 | $311k | 21k | 14.59 |
| 2021-03-31 | $532k | 21k | 24.95 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors